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Surface-enhanced Raman encoded polymer stabilized 
gold nanoparticles: demonstration of potential for use 
in bioassays 
T. L. Schiller,a,b* D. J. Keddie,c I. Blakey,d,e and P.M. Fredericksa*  
 
The preparation of biotinylated, self-assembled polymer stabilized gold nanoparticle hybrids 
encoded with a SERS active compound is described. The polymers used for nanoparticle 
stabilization are carefully designed for this purpose and are synthesized by the RAFT 
polymerization process, as the thiocarbonylthio end group provides a functional handle for 
anchoring the polymers to the gold surface. Functionalized biotin moieties are attached to the 
hybrid nanoparticles via Cu-catalyzed azide-alkyne cycloaddition. Binding of the biotinylated 
hybrid nanoparticles to streptavidin was confirmed by nanoparticle detection and identification 
by the SERS spectrum of the surface-bound SERS active compound, quinoline thiol. This 
investigation includes the requisites that constitute a bioassay, demonstrating the potential of 
polymer-coated hybrid nanoparticles for this purpose.  
Introduction 
Fluorescence labelling has found considerable use for detection 
of binding events in bioassays due to its inherent sensitivity and 
ease of implementation.1 However, due to broad intrinsic band 
widths, the number of analytes in an assay is limited. 
Fluorescence labelling also has other inherent problems, 
including autofluorescence of the substrate, photobleaching of 
the dyes, and the need to use multiple excitation sources.2-4 An 
alternative strategy for bioassays is based on gold nanoparticles 
(AuNPs), with surface enhanced Raman spectroscopy (SERS) as 
the detection technique. SERS has the potential for greater 
specificity than fluorescence and does not suffer from the 
obstacles noted above.2-5 The narrow bandwidths associated with 
the SERS technique (~20 cm-1) provides the potential to achieve 
much greater levels of multiplexing than is possible with 
fluorescence, significantly improving the prospects for increased 
assay throughput. Recently, a number of papers have reported 
the use of AuNPs labelled with a SERS active compound (SAC) 
for use in protein bioassays.2-7 The function of the SAC is to 
detect and also differentiate between different AuNPs and has 
been likened to a “molecular barcode”. The use of NPs brings its 
own problems, the most important of which is the poor long-term 
stability of the NP suspensions. Our strategy to overcome this 
has been to prepare SAC-encoded AuNPs stabilized by RAFT 
polymers,8 through surface binding of the polymer to Au via the 
thiocarbonylthio group.9-19  
 Here we demonstrate a model bioassay in which binding to
 a streptavidin substrate is detected by SERS. This was achieved 
through the synthesis of polymer stabilized AuNPs 
functionalized with a biotin moiety, introduced through the 
polymer end-group. A schematic of this strategy is given in 
Figure 1. Whilst biotinylated polymer-stabilized AuNPs have 
been previously in the literature,17 with turbidity of the solution 
used to detect a binding event to avidin, detection of the event by 
SERS as described herein provides more definitive proof  of 
bioconjugation. 
 There are a number of approaches for the synthesis of 
polymers with defined architecture; one of the most successful 
in recent years has been the reversible addition-fragmentation 
chain transfer (RAFT) process.18, 19 RAFT polymerization is 
applicable to a wide range of monomers and, under appropriate 
conditions, produces polymers with controlled molecular weight 
and low dispersity. These properties are brought about by use of 
a thiocarbonylthio chain transfer (or RAFT) agent.20  A 
feature of RAFT polymerization is the conservation of the 
thiocarbonylthio functionality as the -end-group in the final 
polymer (see Scheme 1). This provides a functional handle in 
which to incorporate additional functionality.21, 22 The polymers 
were designed to have one end-group (‘ZCS2’) to specifically 
bind to the surface of the AuNPs, pendant polyethyleneglycol 
(PEG) chains, which exhibit low non-specific binding and the α-
end-group (‘R’ group) carries an alkyne functionality, amenable 
to the Cu-catalyzed click reaction, which can be used to attach 
biologically active moieties required for bioassays. 
 
Figure 1: Schematic showing the assembly of hybrid NPs for use in bioassays with SERS detection 
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 Scheme 1: Generic scheme for RAFT polymerization 
 
Results and discussion  
For the assembly of the hybrid nanoparticles, we targeted the 
synthesis of a polymer containing poly(ethylene glycol) (PEG) 
pendant groups through the RAFT polymerization of PEG 
methacrylate (PEGMA), because PEG is both water soluble and 
inhibits non-specific binding to proteins.23  
RAFT Agent Synthesis 
To introduce alkyne functionality in the polymer end-group, we 
prepared prop-2-ynyl 2-phenyl-2-
(phenylcarbonothioylthio)acetate (5), bearing the secondary 
benzylic propargyl ester ‘R’ group in moderate yield over two 
steps. Benzylic esters24, 25 allow for simple introduction of end-
group functionality whilst delivering control over the 
polymerization of methacrylic monomers.22, 23 Esterification of 
α-bromophenylacetic acid 1 with propargyl alcohol using DCC 
coupling gave the bromo ester 2 in 37 % yield (see Scheme 2). 
Subsequent reaction with benzodithioate salt 4 (prepared from 
PhMgBr 3 and CS2) gave the alkyne functional dithiobenzoate 
RAFT agent 5 in 38 % yield. 
RAFT Polymerization  
Polymerization of PEGMA 5, in the presence of the acetylene 
RAFT agent 4, gave low dispersity alkyne-functional 
poly(PEGMA) 6 after purification by precipitation (Mn = 7800, 
Đ = 1.10) (see moiety, the synthesis of an azido-functionalized 
biotin analogue was undertaken. For this purpose, 4-(5-
azidopentyl)tetrahydro-1H-thieno[3,4-d]imidazole-2(3H)-one 
(12) can be synthesized from readily available d-biotin 8 (see 
Scheme 4). Fischer esterification of d-biotin27 8 provides the 
ethyl ester 9 in high yield (74 %).  Subsequent reduction with 
diisobutylaluminium hydride (DIBAL)27 furnished the alcohol, 
biotinol 10 in 71 % yield. Attempted tosylation in anhydrous 
pyridine resulted in a mixture of the tosylate 11a (19 %) and 
chloride 11b (16%) (35 % combined yield). This appearance of 
the chloro species 11b in the reaction of biotinol with sulfonyl 
chlorides has been previously observed by Islam et al.28 In this 
report the treatment of biotinol with methanesulfonyl chloride 
gave both the mesylate and chloride. Use of excess pyridine in 
the tosylation reaction, in our case by its use as solvent, can 
facilitate formation of chloro species by reaction of the 
pyridinium chloride by-product with the newly formed 
tosylate.29 Nevertheless, nucleophilic substitution of this mixture 
11 with NaN3 in DMF delivered the requisite biotin azide 12 in 
moderate yield (62 %) (see Scheme 4 for synthetic route). This 
compound was then used to create the biotinylated polymer. 
 
Scheme 3). The presence terminal acetylene unit is evident 
through 1H NMR. This functional group readily undergoes a 
regioselective reaction with azide functionalized molecules via a 
copper-catalyzed azide-alkyne cycloaddition. (CuAAC).20 
Synthesis of Azido-Functional Biotin 
To facilitate functionalization of the polymer with a biotin 
 
Scheme 2: Synthesis of Alkyne-Functional RAFT Agent 4 
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moiety, the synthesis of an azido-functionalized biotin analogue 
was undertaken. For this purpose, 4-(5-azidopentyl)tetrahydro-
1H-thieno[3,4-d]imidazole-2(3H)-one (12) can be synthesized 
from readily available d-biotin 8 (see Scheme 4). Fischer 
esterification of d-biotin27 8 provides the ethyl ester 9 in high 
yield (74 %).  Subsequent reduction with diisobutylaluminium 
hydride (DIBAL)27 furnished the alcohol, biotinol 10 in 71 % 
yield. Attempted tosylation in anhydrous pyridine resulted in a 
mixture of the tosylate 11a (19 %) and chloride 11b (16%) (35 
% combined yield). This appearance of the chloro species 11b in 
the reaction of biotinol with sulfonyl chlorides has been 
previously observed by Islam et al.28 In this report the treatment 
of biotinol with methanesulfonyl chloride gave both the mesylate 
and chloride. Use of excess pyridine in the tosylation reaction, in 
our case by its use as solvent, can facilitate formation of chloro 
species by reaction of the pyridinium chloride by-product with 
the newly formed tosylate.29 Nevertheless, nucleophilic 
substitution of this mixture 11 with NaN3 in DMF delivered the 
requisite biotin azide 12 in moderate yield (62 %) (see Scheme 4 
for synthetic route). This compound was then used to create the 
biotinylated polymer. 
 
 Scheme 3: Synthesis of Alkyne-Functional poly(PEGMA) via RAFT polymerization  
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 Scheme 4: Synthesis of Azido-Functional Biotin 12 
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Polymer-Biotin Conjugation via “Click” Chemistry  
Successful coupling of the biotin azide 12 to the alkynyl 
functional (poly)PEGMA 7 was achieved via CuAAC (Scheme 
5). The progress of the reaction could be observed by a colour 
change from a pale pink (the colour of the polymer brought about 
the chromophore of the RAFT end group) to a dark brown, due 
to a change in oxidation state of the Cu (II) to Cu (0) (from 
disproportionation of Cu(I)). The reaction was monitored for 
completion using ATR-IR spectroscopy, which clearly showed 
the complete loss of the distinctive azide stretching band near 
2100 cm-1 (see Figure 2). Note the band appearing at 3200 cm-1 
is due to the water present. Purification of the biotinylated 
polymer 13 was achieved by centrifugation of the reaction 
mixture, removal of the supernatant and resuspension, which was 
performed in triplicate. The final centrifugation step provided the 
purified polymer as aqueous solution. 
Scheme 4: Polymer-Biotin Conjugation via CuAAC 
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Figure 2: ATR-IR spectra of (a) poly(PEGMA) 6 (b) biotin 
azide (12) (c) initial reaction mixture of biotin azide 11 and 
poly(PEGMA) 7 and (d) reaction mixture of 6 and 11 after 2h.  
The disappearance of the azide peak at 2089 cm-1 is noted by the 
arrow. 
Self-Assembly of Biotinylated Polymer Stabilised AuNPs and 
Tagging with SAC  
The self-assembly of the hybrid NPs was achieved by addition 
of the aqueous solution of biotinylated polymer 13 from above 
into an aqueous citrate stabilized AuNPs solution. The resulting 
polymer stabilized AuNPs could be subsequently phase 
transferred into chloroform, as reported previously,8 for 
simplified isolation. Importantly, this method allows the phase 
transfer of hydrophilic AuNPs after their encapsulation by a 
more hydrophobic polymer, without the addition of a phase 
transfer agent, allowing for the easy removal of citrate and other 
unwanted contaminants. The hybrid AuNPs were isolated from 
chloroform by removal of solvent and resuspended in water. 
Addition of the SAC, 2-quinolinethiol (QSH) to the aqueous 
solution resulted in the QSH tagged AuNPs. Successful polymer 
encapsulation of the AuNPs can be seen in the TEM micrograph 
(see Figure 3). 
 
 
Stability Assessment of Hybrid AuNPs 
The stability of the polymer-stabilized hybrid AuNPs was 
assessed by a comparison between alkyne functional polymer 
hybrid AuNPs and citrate-stabilized AuNPs after addition of 
saturated sodium chloride (NaCl) solution. NaCl is expected to 
destabilize AuNPs because of the rapid change in solubility of 
the nanoparticles.   
 
 
Figure 3: Representative TEM micrograph image of polymer 
stabilised AuNPs 
 The citrate stabilized AuNPs showed complete 
destabilization on addition of NaCl, indicated by a colour change 
from bright pink/purple in solution to black (a sign of 
aggregation) immediately after the NaCl addition.  Within a few 
minutes the now aggregated AuNPs precipitated leaving a black 
film on the bottom of the vessel. The presence of a colourless 
supernatant indicated the absence of AuNPs in solution. An 
example of irreversible aggregation is show in Figure S3 in the 
supporting information. In stark contrast, the addition of NaCl 
solution did not affect the stability of hybrid AuNPs; that is no 
colour change was observed and no change in the surface 
Plasmon resonance (SPR) was detected by visible spectroscopy. 
These observations illustrate that the hybrid AuNPs have 
considerably enhanced stability compared to citrate stabilized 
AuNPs. 
Bioconjugation of Streptavidin 
Due to the remarkable binding affinity of biotin to streptavidin,21 
the interaction between this protein-ligand pair has become a 
commonly used method of bioconjugation.22  To illustrate the 
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potential of polymer stabilized NPs for use as detection 
modalities in bioassays, SERS detection of a binding event 
between streptavidin and the biotinylated hybrid AuNPs was 
undertaken. As streptavidin possesses several biotin binding 
sites, the AuNPs were expected to precipitate from solution 
following the addition of the streptavidin.  Whilst precipitation 
was observed experimentally, this did not provide definitive 
proof a binding event had taken place. Alternatively the 
aggregation may be due to the presence of a salt or another 
destabilizing agent.  
 Since we required further evidence of detection of the biotin 
streptavidin binding to illustrate the viability of our AuNP 
system for bioassay application, an assay where streptavidin is 
surface-bound (an ELISA-like assay)23 was also undertaken. For 
this process a solution of the biotinylated AuNPs was washed 
over a streptavidin functionalized surface. The surface was 
subsequently washed with water to remove any AuNPs adsorbed 
to (but not bound to) the surface. Binding was confirmed by 
SERS. AuNPs without biotin conjugation was compared as a 
negative control.  
 Figure 3 shows the SERS spectra of the RAFT end-group (a) 
the SAC 2-quinolinethiol (b), and the Raman spectrum of 
polystyrene well plate (c). It can be seen that the SERS spectrum 
obtained from the well plate after treatment with the hybrid 
AuNPs (Figure 3 (d)) contains bands around 790, 1080, 1330 and 
1380 cm-1 which accord well with the SERS spectrum of the 
SAC, 2-quinolinethiol (Figure 3(b)). There were also additional 
bands, such as the intense band near 1000 cm-1 together with 
weaker bands at 1050, 1210 and 1600 cm-1, which correspond 
well with the SERS spectrum of the RAFT group. We have 
recently shown that related phenyldithioesters interact strongly 
with the AuNP surfaces through the C=S bond RAFT 
endgroup.31 In the spectrum shown in Figure 3 (a), the intense 
band near 1000 cm-1 can be assigned to the ring breathing mode 
of the aromatic ring, while the less intense bands at 1050, 1210 
and 1600 cm-1 can be assigned to υC-S, υC=S and the C=C 
stretch of the aromatic ring, respectively. Additional contribution 
obtained from the polystyrene substrate can also be observed in 
the SERS spectrum of the biotin-streptavidin surface bound 
AuNPs (Figure 3 (d)).  
 The binding experiment described above was repeated using 
hybrid NPs which were composed of PEGMA which had not 
been biotinylated, but did incorporate the SAC, 2-quinolinethiol. 
After washing the well plate in the same way the Raman 
spectrum did not reveal any bands due to the hybrid AuNPs, 
either from the SERS spectrum of the RAFT end-group, or from 
the SAC. This indicated that, as expected, in the absence of the 
biotin moiety there is no binding to the immobilized streptavidin 
and the hybrid AuNPs were removed from the well during the 
washing procedure.  
 Whilst the SERS spectrum of the bound hybrid AuNPs 
contains bands due to the polystyrene substrate, the existence of 
the SERS spectrum of the SAC is clear. At least four significant 
bands can be seen and their positions uniquely identify both the 
presence and identity of the hybrid AuNPs.   
 In order to further illustrate that the binding event occurred, 
confocal Raman microscopy was employed to examine the 
change in intensity of the SERS signal of both the SAC and the 
RAFT agent, in comparison to the polystyrene substrate.  The 
SERS spectra at varying depths of laser penetration are shown in 
Figure 4, with the peaks arising from each analyte labelled in the 
same fashion as for Figure 3 (RAFT = R; quinolinethiol = Q; 
polystyrene = PS; labels are shown above the top spectrum only 
for clarity). The SERS spectrum of the surface bound NPs, 
measured at the laser focus depth that gave maximum signal  
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Figure 3: SERS spectra of (a) RAFT end group of 13, (b) 2-
quinolinethiol, (c) Raman spectrum of the well plate’s 
polystyrene substrate, and (d) the SERS spectrum after the 
binding event; the major peaks corresponding to the RAFT end-
group of 13, 2-quinolinethiol and polystyrene substrate are 
(d) 
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(b) 
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labelled as R, Q and PS respectively and numbered for ease of 
correlation. 
intensity for the SAC and RAFT agent peaks is shown in Figure 
4 (a). When the depth of focus of the laser was varied from this 
position, then the signal intensity varied. As the depth of focus 
was moved 50 µm toward the substrate the PS peak at 1000 cm-
1 (PS1) becomes more prominent, indicated by a change in the 
relative peak intensity compared to the peak arising from the 
RAFT group at approximately 1200 cm-1 (R2) (see Figure 4 (b)). 
The bare PS substrate is shown for comparison in Figure 4 (c).  
 The change in relative intensity of the peaks at 1000 cm-1 
and 1200 cm-1 suggests there is a contribution to the signal at 
1000 cm-1 arising from the PS substrate. In spite of this, the 
SERS signals from the RAFT group and the SAC are easily 
observed in Figure 4 (a) and clearly illustrate successful binding 
of the biotinylated AuNPs to the streptavidin functionalized 
surface.  
 These results illustrate the potential utility of our SERS 
detected hybrid AuNP system for use in both precipitation and 
ELISA-like surface bound assays. The advantages of each assay 
type can be exploited through their use: (a) the simplicity of 
precipitation assays and (b) the sensitivity of the ELISA/surface 
binding method.  
Conclusions 
In summary, we have synthesized biotinylated polymer-
stabilized hybrid AuNPs incorporating a SAC, 2-quinolinethiol. 
This material interacts strongly with streptavidin immobilized on 
a polystyrene surface and this binding can be detected by the 
SERS spectrum of the SAC. Binding to streptavidin was not 
observed for hybrid AuNPs which did not contain the biotin 
moiety, and no SERS spectrum was observed. The sequence of 
reactions discussed in this paper constitutes a bioassay and hence 
demonstrates the potential for hybrid AuNPs, using tailored 
polymers, to be used as a novel approach to bioassays, with 
SERS as the detection method. The illustration of this procedure 
in multiplexing experiments will be the focus of future 
investigations. 
Experimental  
Materials: Unless otherwise stated, all reagents and solvents were 
used as received.  All water used was MilliQ Ultrapure 18 MΩ cm. 
SigmaScreen™ Streptavidin High Capacity Coated Plates and all 
chemicals were purchased from Sigma Aldrich, with the exception of 
streptavidin and biotin that were purchased from Anaspec. 
Characterization: 1H Nuclear Magnetic Resonance (NMR) 
spectra were collected using a 5 mm BBOz gradient probe at 298 
K on the Bruker Avance 300 MHz and 13C spectra were collected 
using a 5mm SEIz probe at 298K on the Bruker Avance 400 
MHz. Deuterated solvents for NMR spectroscopy were 
commercially obtained (Cambridge Isotopes) and were of 99.8 
atom % D. Chemical shifts () are reported in parts per million 
(ppm) relative to residual solvents.24 Gel permeation 
chromatography (GPC) measurements of the polymers were 
performed using a Waters Alliance 2690 Separations Module 
equipped with an autosampler, column heater, differential 
refractive index detector and a Photo Diode Array (PDA) 
connected in series. HPLC grade tetrahydrofuran was used as the 
eluent at a flow rate of 1 mL min-1. The columns consisted of 
three 7.8 x 300 mm Waters Styragel SEC columns connected in 
series, comprising of two linear Ultrastyragel and one Styragel 
HR3 columns. Polystyrene standards ranging from 2000000-517 
g mol-1 were used for calibration and all GPC derived molecular 
weights are quoted in polystyrene equivalents. Raman spectra 
were recorded with a Renishaw  
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Figure 4: Depth profile confocal Raman microscopy spectra measured at (a) the depth of maximum Raman peak intensity, (b) 50 
µm toward the substrate from the point of maximum signal intensity, and (c) the polystyrene substrate.  
Model 1000 micro Raman spectrometer (Renishaw plc, Wotton-
under-Edge, UK) equipped with a 785 nm excitation source from a 
diode laser, a single diffraction grating and an electrically cooled 
CCD detector. A 10 % neutral density filter was used, which resulted 
in a laser power at the sample of about 1 mW. A single accumulation 
in the spectral range 2000–200 cm-1 was collected for each sample. 
Confocal mode with a pinhole inserted was used for measurements 
taken on the streptavidin well plate. Transmission Electron 
Microscopy (TEM) micrographs were imaged on a JEOL 1200 
TEM, where the energy was set to 80 kV and spot size 3. Solutions 
of citrate AuNPs in water and solutions of polymer stabilised AuNPs 
in chloroform were dropped onto carbon-celloidin coated 200-mesh 
copper TEM grids and allowed to dry before placing in TEM sample 
holder.  Citrate stabilised AuNPs that were dispersed in water, were 
synthesised using the citrate method.25, 26 Size of the nanoparticles 
was confirmed on a Joel 1200 TEM. TEM micrographs of AuNPs 
synthesised by the citrate method were analysed and average size 
was taken.  Samples were mounted on celloidin – carbon coated 200 
mesh copper grids. It should be noted that the NPs aggregated on the 
carbon coated TEM grids during sample preparation. Attenuated 
Total Reflectance - Fourier Transform Infrared (ATR-FTIR) spectra 
were obtained on a Nicolet Nexus 5700 FTIR spectrometer equipped 
with a Nicolet Smart Orbit single bounce, germanium ATR 
accessory (Thermo Electron Corp., Waltham, MA). Spectra were 
recorded at 4 cm-1 resolution for at least 32 scans with an OPD 
velocity of 0.6289 cm s-1. Solids were pressed directly onto the Ge 
internal reflection element of the ATR accessory without further 
sample preparation. Spectra were manipulated using the OMNIC 7 
software package (Thermo Electron Corp., Waltham, MA).  
Synthesis of prop-2-ynyl 2-phenyl-2-
(phenylcarbonothioylthio)acetate (acetylene RAFT agent, 4) 
Part 1: Esterification reaction (synthesis of prop-2-ynyl 2-bromo-2-
phenylacetate, 2) 
Propargyl alcohol (1.21 g, 21.62 mmol, 1 equiv) was dissolved in 
DCM (12.5 mL). α-Bromophenylacetic acid  (5.58 g, 25.93 mmol, 1.2 
equiv) and 4-(dimethylamino)pyridinium 4-toluenesulfonate (DPTS) 
(1.27 g, 4.32 mmol, 0.2 equiv) were then added to the solution.  N,N’-
Dicyclohexylcarbodiimide (DCC) (6.69 g, 32.40 mmol, 1.5 equiv) 
was dissolved in a separate flask in DCM (12.5 mL) and then 
transferred slowly to the reaction vessel. Upon addition of the DCC, 
the reaction mixture became cloudy as DCC urea was produced. The 
reaction was stirred overnight at room temperature under Ar to ensure 
completion, after which the reaction mixture was filtered to remove 
the precipitate.  The DCM solvent was removed under vacuum 
leaving an oily yellow residue. This was purified by column 
chromatography (SiO2, eluent: n-hexane) to give the desired 
propargyl ester 2 as a clear, colourless oil (1.97 g, 8.0 mmol, 37 %); 
1H NMR (400 MHz, CDCl3) δ ppm 2.54 (1H, t, J = 2.3 Hz, C≡CH), 
4.76 (1H, dd, J = 2.3 and 15.3 Hz, HCHC≡CH), 4.82 (1H, dd, J = 2.3 
and 15.3 Hz, HCHC≡CH), 5.42 (1H, s, CBrH), 7.34-7.44 (3H, m, 
ArH), 7.54-7.61 (2H, m, ArH), 13C NMR (100 MHz, CDCl3) δ ppm 
45.9 (alkyl C), 53.7 (alkyl C), 75.8 (C≡C), 76.5 (C≡C), 128.6 (ArC), 
128.8 (ArC), 129.4 (ArC), 135.1 (ArC), 167.5 (C=O) 
 
Part II: Synthesis of acetylene RAFT agent (prop-2-ynyl 2-phenyl-2-
(phenylcarbonothioylthio)acetate, 4)  
Phenyl magnesium bromide (PhMgBr), was prepared by placing 
pre-dried magnesium (0.561 g, 23.38 mmol, 3 equiv) and a couple of 
small crystals of iodine in a 50 mL oven-dried two-neck round-
bottomed flask. The flask was then attached to a Schlenk manifold via 
a reflux condenser. The flask was flame-dried under high vacuum, 
resulting in a fine coating of iodine on the magnesium. The vessel was 
then placed under argon for the remainder of the reaction. 
Et2O (dried over Na wire) (10 mL) was added to the reaction vessel.  
Subsequently, bromobenzene (0.99 mL, 1.47 g, 9.35 mmol, 1.2 equiv) 
was added dropwise ensuring the reaction occurred at a constant rate.  
When the addition was complete, the reaction was stirred until all 
activity subsided.  The solution of Grignard reagent, PhMgBr, was 
then quantitatively transferred in a dry, gas-tight syringe to a clean 
oven-dried 3-neck flask, attached to a reflux condenser.   
Subsequently, dry THF (20 mL) was added to the PhMgBr 
solution.  CS2 was added drop wise using a dry glass syringe and 
needle, and the solution became dark red-brown. After the addition 
was complete, the reaction was heated to 50 °C for 30 min to ensure 
full conversion. A solution of prop-2-ynyl 2-bromo-2-phenylacetate 
(1.98 g, 7.79 mmol, 1 equiv) in dry THF (20 mL) was then added to 
the reaction vessel.  The flask was covered with Al foil to minimize 
degradation of the product by light and stirred at 80 °C for 15 hours 
and subsequently the solvent was removed under vacuum.  
Purification by column chromatography (50% CHCl3/50% n-hexane) 
gave the acetylene RAFT agent 4 as a red oil (0.92 g, 2.81 mmol, 38 
%); FT-IR ATR (cm-1): 2920, 1691, 1588, 1463, 1443; 1H NMR (400 
MHz, CDCl3) δ ppm 2.52 (1H, t, J = 2.3 Hz, C≡CH), 4.73 (1 H, dd, J 
= 2.3 and 15.3 Hz, HCHC≡CH), 4.84 (1 H, dd, J = 2.3 and 15.3 Hz, 
HCHC≡CH), 5.77 (1H, s, SCHPh), 7.36-7.61 (8H, m, ArH), 8.00-8.06 
(2H, m, ArH)  13C NMR (100 MHz, CDCl3) δ ppm 53.6 (alkyl C), 
58.6 (alkyl C), 75.7 (C≡C), 76.9 (C≡C), 127.0 (ArC), 128.5 (ArC), 
128.9 (ArC), 129.1 (ArC), 129.2 (ArC), 132.6 (ArC), 132.9 (ArC), 
143.8 (ArC), 168.2 (C=O), 225.7 (C=S). 
 
 Synthesis of poly(PEGMA) 6 using the acetylene RAFT agent 4 
The acetylene RAFT 4 agent was used to synthesize a PEGMA 
polymer by RAFT polymerization as follows:  Poly(ethylene glycol) 
methacrylate 5 (Mn=475, PEGMA) (3 g, 6.32 mmol) was weighed into 
a Schlenk flask, then benzene (3.3 g) was added.  2,2’-
Azobisisobutyronitrile (AIBN) (12.9 mg, 0.078 mmol) was added to 
the flask, along with the RAFT agent 4 (257.1 mg, 0.789 mmol) 
([PEGMA]:[RAFT]:[AIBN] = 8:1:0.1).  The mixture was purged 
under argon for approximately 15 minutes then sealed and placed in 
an oil bath at 70 °C for 15 h. Crude samples were taken from the 
mixture and characterized by NMR and GPC analysis to ascertain full 
monomer conversion and molecular weight. The resulting polymer 
was dissolved in a small amount of DCM and purified by precipitation 
into cold diethyl ether.  The ether was then removed by decantation to 
give the polymer 6 as a pink gum. Further NMR and GPC analysis of 
the polymer 6 confirmed the removal of the starting materials (NMR 
in Figure S1 and S2 of the supporting information); (GPC: Mn = 7800, 
Mw = 8600, Mw/Mn = 1.10). 
 
Synthesis of 4-(5-Azidopentyl)tetrahydro-1H-thieno[3,4-
d]imidazole-2(3H)-one 11 
Synthesis of Ethyl [(3aS,4S,6aR)-2-oxo-hexahydro-thieno[3,4-
d]imidazol-4-yl]pentanoate (8)  
Biotin 7 (1.0 g, 4.09 mmol) was dissolved in absolute ethanol (25 
mL) and the resulting solution was acidified by adding several drops 
of conc. H2SO4.  The reaction mixture was stirred at room temperature 
for 16 h, after which the volatiles were removed under reduced 
pressure. The crude product was taken up in DCM (50 mL), and 
washed with saturated NaHCO3 (3 × 30 mL) and H2O (2 × 30 mL).  
The organic layer was dried (Na2SO4) and the solvent was removed 
under reduced pressure to give a white solid. Recrystallisation from 
cold acetone gave ethyl [(3aS,4S,6aR)-2-oxo-hexahydro-thieno[3,4-
d]imidazol-4-yl]pentanoate (8) as a white crystalline solid (0.82 g, 
3.01 mmol, 74 %). FT-IR ATR: 3236, 2926, 2861, 1731, 1709, 1478, 
1284 cm-1; 1H NMR (400 MHz, CDCl3) δ ppm 6.00 (s, 1H), 5.61 (s, 
1H), 4.53-4.43 (m, 1H), 4.32-4.24 (m, 1H), 4.09 (q, J = 7.13 Hz, 2H), 
3.25-3.03 (m, 1H), 2.88 (dd, J = 12.80, 4.96 Hz, 1H), 2.71 (d, J = 12.78 
Hz, 1H), 2.30 (t, J = 7.50 Hz, 2H), 1.77-1.54 (m, 4H), 1.52-1.33 (m, 
2H), 1.23 (t, J = 7.13 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ ppm 
173.686, 163.744, 61.931, 60.284, 60.101, 55.443, 40.530, 33.933, 
28.328, 28.220, 24.781, 14.232; HRMS mass calculated for 
C13H23N2O3S+: 273.1195 experimental ESI [M+H]+: 273.1273. 
 
Synthesis of 4S-[(3aS,6aR)-5-Hydroxy-pentyl]-tetrahydro-
thieno[3,4-d]imidazol-2-one (9) 
Biotin ethyl ester 8 (200 mg, 0.733 mmol) was dissolved in DCM 
(0.7 mL) and placed under argon and cooled to -78 °C (dry 
ice/acetone). Diisobutylaluminium hydride (DIBAL) (1.72 mL, 2.5 
mmol, 1.5 M in toluene) was added dropwise over 10 minutes. The 
mixture was stirred at -78 °C for a further 20 minutes then allowed to 
warm to room temperature and stirred for 16 h. The mixture was again 
cooled to -78 °C and quenched by dropwise addition of methanol, a 
mixture of methanol and water and finally water. The solvents were 
removed under reduced pressure and the product was extracted with 
ethanol using a Soxhlet apparatus.  Subsequently the EtOH was 
removed under reduced pressure to give an off white solid.  
Purification by column chromatography (50 % EtOAc/50 % EtOH) 
gave 4S-[(3aS,6aR)-5-hydroxy-pentyl]-tetrahydro-thieno[3,4-
d]imidazol-2-one (9) as a white solid (119 mg, 0.517 mmol, 71 %); 
FT-IR ATR: 3244, 2931, 2369, 1700, 1477cm-1; 1H NMR (400 MHz, 
MeOH-d4 6.62 (s, 1H), 6.58 (s, 1H), 4.56-4.46 (m, 1H), 4.35-4.29 (m, 
1H), 3.57 (t, J = 6.50, 6.50 Hz, 2H), 3.27-3.19 (m, 1H), 2.95 (dd, J = 
12.76, 4.98 Hz, 1H), 2.72 (d, J = 12.72 Hz, 1H), 1.91 (s, 1H), 1.83-
1.35 (m, 1H); 13C NMR (100 MHz), MeOH- 62.0, 
61.5, 55.8, 39.6, 33.5, 32.0, 28.8, 28.4, 25.5. HRMS mass calculated 
for C10H19N2O2S+: 231.1089 experimental ESI [M+H]+: 231.1167. 
These data were found to have some discrepancy compared with those 
reported in literature.27, 28 It is suggested that some of the NMR data 
may have been misreported as the product reported in literature was 
not purified after the Soxhlet extraction.  
  
Synthesis of 4S-[(3aS,6aR)-5-(4-toluenesulfonyl)pentyl]-tetrahydro-
thieno[3,4-d]imidazol-2-one (10a) (4S-[(3aS,6aR)-5-chloropentyl]-
tetrahydro-thieno[3,4-d]imidazol-2-one (10b)) 
Biotinol 9 (119 mg 0.57 mmol) was dissolved in warm anhydrous 
pyridine (2.5 mL) under argon.  This solution was cooled in an ice 
bath for 30 minutes after which p-toluenesulfonyl chloride (120 mg, 
0.63 mmol, 1.1 equiv.) was added.  After stirring at 0 °C for 5 minutes 
the reaction mixture was allowed to warm to RT and was stirred for a 
further 16 h.  The mixture was poured into cold water (~50 mL)  and 
extracted with DCM (3 × 50 mL).  The DCM solutions were then 
washed with 1.8 M H2SO4 (3 × 50 mL).  The aqueous layers were 
extracted with additional DCM (2 × 150 mL). The DCM layers were 
combined and subsequently washed with brine (3 × 100 mL) and dried 
over Na2SO4.  The solvent was removed and the obtained solid was 
purified by column chromatography (1:20 MeOH:DCM). NMR and 
MS characterisation of the obtained product indicated the presence of 
both tosyl 10a and chloro 10b functionalised biotin (60 mg, 19 % 10a, 
16 % 10b (concentrations from NMR), 0.2 mmol, 35 % overall yield). 
Further attempts to separate these proved unsuccessful and the 
mixture was used in subsequent steps without additional purification.  
Tosylate 10a 1H NMR (400 MHz, CDCl3 ) δppm 7.79 (d, 2H, 
J=8.1 Hz), 7.36 (d, J=8.1 Hz, 2H),  6.34 (s, 1H), 5.65 (s, 1H), 4.56-
4.50 (m, 1H), 4.03 (t, J = 6.4 Hz, 2H), 3.22-3.07 (m, 1H), 2.94-2.87 
(m, 1H), 2.76 (d, J = 5.7 Hz, 1H), 2.46 (s, 3H), 1.83-1.30 (m, 8H); 13C 
NMR (100 MHz, CDCl3) δ ppm 163.9, 144.7, 133.0, 129.8, 127.8, 
77.2, 70.6, 60.0, 55.6, 28.5, 28.3, 28.3, 25.3, 21.6; HRMS calculated 
for tosylate C17H24N2O4S2: 384.12 experimental ESI [M+H]+: 
385.1256; 
Chloride 10b 1H NMR (400 MHz, CDCl3) δ ppm 6.05 (s, 1H), 5.73 
(s, 1H), 4.36-4.30 (m, 1H), 3.54 (t, J = 6.7 Hz, 2H), 3.22-3.07 (m, 1H), 
2.96-2.87 (m, 1H), 2.73 (d, J = 5.7 Hz, 1H), 1.54-1.31 (m, 8H); 13C 
NMR (100 MHz, CDCl3) δppm 163.8, 61.9, 60.0, 55.5, 45.0, 40.5, 
32.2, 28.4, 28.2, 26.7; HRMS calculated for chloride C10H17N2SOCl: 
248.0750 experimental ESI [M+H]+: 249.0828. These data agree with 
both biotin tosylate and biotin chloride.27, 29  
 
Synthesis of 4-(5-Azidopentyl)tetrahydro-1H-thieno[3,4-d]imidazole-
2(3H)-one 11 
To the biotin tosylate/chloride mixture 10 (60 mg, 0.2 mmol) and 
sodium azide (32 mg, 0.6 mmol, 3.2 equiv.) was added to DMF (0.5 
mL).  The resultant solution was heated at 100 °C for 5 hours. The 
reaction mixture was cooled and water was added forming a white 
precipitate. Filtration of the precipitate gave 4-(5-
azidopentyl)tetrahydro-1H-thieno[3,4-d]imidazole-2(3H)-one 11 (30 
mg, 0.117 mmol, 62 %) mp: 85 °C; FTIR ATR showed a characteristic 
azide peak at 2100 cm-1; (400 MHz, CDCl3) δ ppm 1.55-1.36 (m, 4H), 
1.85-1.57 (m, 8H), 2.76 (d, J = 12.81 Hz, 1H), 2.95 (dd, J = 12.84, 
5.05 Hz, 1H), 3.22-3.15 (m, 1H), 3.29 (t, J = 6.83, 6.83 Hz, 2H), 4.38-
4.29 (m, 1H), 4.57-4.50 (m, 1H), 5.21 (s, 1H), 5.47 (s, 1H); 13C NMR 
(100 MHz, CDCl3) δ ppm 163.3, 62.1, 60.1, 55.5, 51.4, 40.6, 28.6, 
28.6, 26.7; HRMS mass calculated for C10H18N5OS+: 256.1154 
experimental ESI [M+H]+: 256.1232. 
 
Gold Nanoparticle Synthesis  
Gold nanoparticles were prepared as we reported previously,8 via 
adaption of the method reported by Grabar et al.30 
Briefly, an aqueous solution of chloroauric acid (HAuCl4) (100 
mL, 1.0 mM) was heated to boiling, after which an aqueoussolution 
of sodium citrate (3.5 mL, 38.8 mM) was added. To ensure complete 
reduction, the solution was boiled for a further 15 min. The reaction 
was cooled to room temperature and stored as an aqueous suspension 
of AuNPs. All characterization data was consistent with that reported 
previously.8 
 
Polymer Biotin Conjugation 
The copper-catalyzed azide-alkyne cycloaddition (CuAAC) was 
first performed in water to test the reaction, since it is reported to 
proceed more readily in aqueous media. Both 1H NMR and FTIR-
ATR were used to monitor the disappearance of the azide 
functionality.  These reactions were performed with an excess of the 
acetylene coupling partner (in this case the PEG homopolymer 2) to 
ensure complete conversion of the azide.  
 
Preparation of biotin functionalized AuNPs: CuAAC of hybrid 
gold polymer nanoparticle with biotin azide.  
The poly(PEGMA)12 (74 mg) was dissolved in 1 mL water.  Biotin 
azide 11 (1.1 mg) was added to the vial, from an 11 mg/1 mL solution.  
The reagents were made up to 1 mL each (13 mg CuSO4·5H2O and 
16 mg of sodium ascorbate respectively) into water so that 100 µL 
could be added to the vial and the reaction(s) stirred for 24 hours.  
Purification was conducted by centrifugation. 
Approximately 1mL AuNPs solution was placed in a clean vial.   
The biotin polymer product (100 µL) was added to the AuNPs and 
followed approximately 60 seconds later by 5, 10 or 200 µL of a 54 
µM solution of 2-quinolinethiol (QSH) and the resultant mixture was 
stirred overnight, to allow the QSH to penetrate into the polymer. The 
reaction was monitored for completion using ATR-IR with a Ge 
crystal.  
Approximately 1 mL of AuNP solution was placed in 10 separate 
vials, so that reproducibility could be ascertained.  Poly(PEGMA)12 
(35 mg) was dissolved in water (10 mL).  Subsequently, 0.5 mL of the 
polymer solution was added to the AuNP vial.  This was shaken and 
then set aside for an hour to allow attachment of the polymer to the 
nanoparticle surface.  Stability of the AuNPs was assessed by the 
addition of NaCl to a vial of the hybrid AuNPs (not incorporating 
biotin) and to a vial of citrate stabilised AuNPs. 
 
Demonstration of binding to streptavidin.  
The SigmaScreen™ Streptavidin High Capacity Coated Plates 
were obtained from Sigma Aldrich. The AuNP/biotin-conjugate 
polymer 12 solution (200 µL, as prepared) was added to each well on 
the well plate. The well plates were left to rest at RT for at least 2 
hours and then washed vigorously with PBS and 5 % tween 20 to 
remove any unbound material. SERS was used to analyse the presence 
of a signal to indicate the binding event.   
The biotin was added to a well plate that had been pre-treated with 
streptavidin.  Instructions supplied by Sigma with the well plate meant 
that approximately 200 µL of the AuNP/biotin solution needed to be 
added to individual wells on the well plate. This was left at RT for at 
least 2 hours then washed vigorously with PBS (phosphate buffered 
saline) and 5 % tween 20 (mild surfactant). The streptavidin solutions 
for this study were prepared at a concentration of 5 × 10-6 M in 0.5 M 
aqueous NaCl. 
The SERS signal of solution and plate was examined before and 
after washing.  Control samples were also analysed, using AuNPs with 
a SERS tag but no biotin attached.  Wells were prepared using the 
above procedure except without any biotin present. 
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